Advances in the Treatment of Psychiatric Disorders: Innovations and Future Directions

Course Open/Close: Sep 11, 2019 - Mar 25, 2027

This Virtual Grand Rounds series examines research and advances across a variety of psychiatric conditions. It addresses many clinical challenges and barriers to treatment. These twenty sessions are ideal education for professionals in psychiatry, primary care, nursing, psychology and family practice. In fact, you can use this free series to educate your entire staff in a community hospital or practice of any size. Or simply stay up-to-date as an individual clinician. The series provides CME/CE credits for physicians, psychologists, nurses and social workers. You can view the entire series or a single session at any time during the year.

Available Credits: 20.00 AMA PRA Category 1 Credit™ 20.00 Nursing Contact Hours 20.00 Participation 20.00 Psychologists CE Credit Register For This Course

Course Details

This Virtual Grand Rounds series examines research and advances across a variety of psychiatric conditions. It addresses many clinical challenges and barriers to treatment. These twenty sessions are ideal education for professionals in psychiatry, primary care, nursing, psychology and family practice.

In fact, you can use this free series to educate your entire staff in a community hospital or practice of any size. Or simply stay up-to-date as an individual clinician. The series provides CME/CE credits for physicians, psychologists, nurses and social workers. You can view the entire series or a single session at any time during the year.

Every session is led by clinician-researchers from the Massachusetts General Hospital Department of Psychiatry. These are just a few of the topics the series addresses:

  • Novel approaches to treating depression.
  • Effective strategies for treating psychosis in the context of mood disorders
  • Diagnosis and treatment of Mood Disorders in patients with Attention Deficit Hyperactivity Disorder (ADHD)
  • Mood Disorders and sleep.
  • Mood Disorders and substance use.
  • Bipolar Disorder or ADHD? Implications for diagnosis and treatment.
  • Pharmacogenomics testing for refractory depression
  • Treating the “other” symptoms in Mood Disorders – low energy, low appetite, and others
  • ECT and rTMS – novel treatment

Course Summary

Available Credits:20.00 AMA PRA Category 1 Credit™ 20.00 Nursing Contact Hours 20.00 Participation 20.00 Psychologists CE Credit
Course Topic:Cognitive Behavioral Therapy, Depression, Anxiety, Psychosis
Course Format:On-Demand Course
Target Audience:

This program is intended for:

  • Physicians
  • Psychologists
  • Primary Care/ Family Physicians
  • Clinical Nurse Practitioners 
  • Allied Health Service Providers 

Accreditation
In support of improving patient care, MGH Institute of Health Professions is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.  

This program is intended for psychiatrists, psychologists, general and family practice physicians, psychiatric nurses, physician assistants, nurse practitioners, and social workers. Participants can receive up to 20.0 CE.

20.0  Psychologists:

Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibly for the content of the programs. MGH Institute of Health Professions designates this activity for 20.0 CE credit.


20.00 Physicians

MGH Institute of Health Professions designates this live activity for a maximum of 20.0 AMA PRA Category 1 Credits ™. Physicians should claim only credit commensurate with the extent of their participation in this activity.


20.0 Nursing Contact Hours

MGH Institute of Health Professions designates this activity for 20.0 contact hours for nurses.

 

 

Course Opens: Sep 11, 2019
Course Closes: Mar 25, 2027
Cost: Free

Learning Objectives

By the end of this program, participants should be able to:

  • Identify novel and innovative evidence-based psychopharmacological strategies for treating depression.
  • Review contemporary strategies for assessing and managing sleep disorders in the context of mood disorders.
  • Review the current evidence-based assessment and treatment of schizophrenia and psychosis in the context of mood symptoms.
  • Review effective, research-driven strategies for identifying and treating opiate use disorders and other substance use disorders in the context of other psychiatric disorders.
  • Recognize bipolar disorder in the context of ADHD.
  • Describe the role of ECT and rTMS in the treatment of psychiatric illness.
  • Recognize and manage barriers to effective treatment of mood disorders including symptoms of fatigue, anorexia, and others.
  • Review the benefits and limitations of pharmacogenetic testing to guide choice of pharmacotherapy in the treatment of psychiatric disorders.

We have a dedicated staff member who is available by phone 5 days per week between 8 am and 5 pm by calling 866-644-7792 or email at mghcme@mgh.harvard.edu. All inquiries will be dealt with in a timely  (within one business day) and professional manner. Requests for credits or refunds will be reviewed by the Director of the Division of Professional and Public Education, Massachusetts General Hospital. Please refer to our cancellation policy for additional information.”